RAGE Deletion Confers Renoprotection by Reducing Responsiveness to Transforming Growth Factor-β and Increasing Resistance to Apoptosis
Shinji Hagiwara(Baker Heart and Diabetes Institute), Phillip Kantharidis(Diabetes Australia), Assam El‐Osta(University of Copenhagen), Josephine M. Forbes(Translational Research Institute), Mark Ziemann(Baker Heart and Diabetes Institute), Eoin Brennan(Baker Heart and Diabetes Institute), Muthukumar Mohan(Monash Alfred Psychiatry Research centre), Melinda T. Coughlan(Baker Heart and Diabetes Institute), Mark E. Cooper(Australian Regenerative Medicine Institute), Tieqiao Wu(Baker Heart and Diabetes Institute), Brooke E. Harcourt(Albert Einstein College of Medicine), Gavin C. Higgins(Victorian Cancer Biobank), Bo Wang(Sichuan Agricultural University), Aaron McClelland(Baker Heart and Diabetes Institute), Karly C. Sourris(Baker Heart and Diabetes Institute), R. J. Pickering(Baker Heart and Diabetes Institute), Sally A. Penfold(Albert Einstein College of Medicine), Merlin C. Thomas(Monash University)
Cited by 22
Related Papers
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k
Diabetic kidney disease
|Nature Reviews Disease Primers|2015|1.2k
Follow-up of Blood-Pressure Lowering and Glucose Control in Type 2 Diabetes
|New England Journal of Medicine|2014|624
RAGE-Induced Cytosolic ROS Promote Mitochondrial Superoxide Generation in Diabetes
|Journal of the American Society of Nephrology|2009|461